Jacobs Engineering Group Inc. has been awarded a contract from Novo Nordisk for a research and development facility in Bagsværd, Denmark. Under the terms of the contract, Jacobs is providing engineering, procurement, and construction management services for a new purification pilot plant project, which initially involves one purification line.

The project is expected to expand Novo Nordisk's capacity to produce active pharmaceutical ingredients for a growing number of diabetes drugs in development. The pilot plant is expected to be fully operational by late 2016. The facility has the potential to be expanded twofold in the future to provide further production capacity. The new purification pilot plant is intended to increase Novo’s capacity for early-phase diabetes projects.

Source: Jacobs Engineering